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Abstract
AIM: To establish a mouse model of alcohol-driven 
hepatocellular carcinoma (HCC) that develops in livers 
with alcoholic liver disease (ALD).
METHODS: Adult C57BL/6 male mice received multiple 
doses of chemical carcinogen diethyl nitrosamine (DEN) 
followed by 7 wk of 4% Lieber-DeCarli diet. Serum 
alanine aminotransferase (ALT), alpha fetoprotein 
(AFP) and liver Cyp2e1 were assessed. Expression 
of F4/80, CD68 for macrophages and Ly6G, MPO, 
E-selectin for neutrophils was measured. Macrophage 
polarization was determined by IL-1β/iNOS (M1) and 
Arg-1/IL-10/CD163/CD206 (M2) expression. Liver 
steatosis and fibrosis were measured by oil-red-O and 
Sirius red staining respectively. HCC development was 
monitored by magnetic resonance imaging, confirmed 
by histology. Cellular proliferation was assessed by 
proliferating cell nuclear antigen (PCNA).
RESULTS: Alcohol-DEN mice showed higher ALTs 
than pair fed-DEN mice throughout the alcohol 
feeding without weight gain. Alcohol feeding resulted 
in increased ALT, liver steatosis and inflammation 
compared to pair-fed controls. Alcohol-DEN mice had 
reduced steatosis and increased fibrosis indicating 
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advanced liver disease. Molecular characterization 
showed highest levels of both neutrophi l and 
macrophage markers in alcohol-DEN livers. Importantly, 
M2 macrophages were predominantly higher in 
alcohol-DEN livers. Magnetic resonance imaging 
revealed increased numbers of intrahepatic cysts 
and liver histology confirmed the presence of early 
HCC in alcohol-DEN mice compared to all other 
groups. This correlated with increased serum alpha-
fetoprotein, a marker of HCC, in alcohol-DEN mice. 
PCNA immunostaining revealed significantly increased 
hepatocyte proliferation in livers from alcohol-DEN 
compared to pair fed-DEN or alcohol-fed mice.
CONCLUSION: We describe a new 12-wk HCC model 
in adult mice that develops in livers with alcoholic 
hepatitis and defines ALD as co-factor in HCC.
Key words: Alpha-fetoprotein; Macrophage polarization; 
Steatohepatitis; Proliferating cell nuclear antigen; Liver 
tumor
© The Author(s) 2016. Published by Baishideng Publishing 
Group Inc. All rights reserved.
Core tip: Chronic alcohol consumption leads to broad 
spectrum of disorders from steatosis to steatohepatitis 
to cirrhosis and hepatocellular cancer (HCC). Currently 
there are no animal models of HCC that evaluate effect 
of alcoholic liver disease (ALD) on HCC acceleration. 
We describe a new 12-wk HCC model in adult mice 
that develops in livers with alcoholic hepatitis and 
defines ALD as co-factor in HCC. Our model involves 
sequential step-wise progression of ALD to HCC and 
highlights the role of alcohol as a tumor promoting 
agent. Importantly, our model shows inflammation, 
cellular regeneration, and fibrosis, all the features of 
human HCC pathogenesis.
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INTRODUCTION
Hepatocellular carcinoma (HCC) is the most common 
liver cancer, and worldwide it represents the fifth most 
common primary cancer diagnosed in patients[1]. 
HCC is also the third leading cause of cancer related 
mortality globally. In the United States, the incidence 
of HCC has tripled over the last two decades[2]. Unlike 
many other cancers with known associated risk 
factors, the underlying molecular pathophysiology for 
HCC is still not completely known. Most commonly, 
the incidence of HCC is linked to known risk factors 
including hepatitis B and C, aflatoxin and chronic 
alcohol drinking[3]. About 40% of individuals who 
chronically consume alcohol develop fatty liver, the 
first pathological condition that, with continued alcohol 
use, can advance to alcoholic hepatitis and cirrhosis[4]. 
In humans, alcohol is a known causal agent in the 
development of HCC[1]. Most HCC patients have a 
history of chronic liver disease and cirrhosis and 
cirrhosis remains the single common precursor to HCC 
development[5].
Increasing evidence suggests that chronic tissue 
inflammation promotes tumor development[6]. In 
alcoholic hepatitis recruitment of macrophages and 
neutrophils to the liver and activation of resident 
Kupffer cells results in high levels of pro-inflammatory 
cytokines (TNFa, IL-1β, MCP-1, IL-6) both in the liver 
and systemic circulation[7]. Because alcoholic liver 
disease (ALD) and alcoholic hepatitis are characterized 
by significant liver inflammation, here we hypothesized 
that the alcoholic liver environment may expedite HCC 
development. 
Hepatocarcinogenesis is a multistep, multistage 
process that involves genetic and epigenetic alterations 
that ultimately lead to malignant transformation of 
hepatocytes[8]. Several animal models have been 
reported that mimic different steps leading to HCC. 
These models have helped to identify molecular 
mechanisms that underlay the development of 
HCC including genetically modified mouse models, 
transgenic models expressing viral genes, transgenic 
mice over-expressing oncogenes and transgenic 
models over-expressing growth factors[9,10]. Although 
valuable in facilitating detailed investigation of 
molecular pathways, the genetically modified animal 
models have been shown to vary significantly in their 
pattern of HCC development[10]. Of the chemically 
induced HCC animal models, the N-nitrosodiethylamine 
(DEN) based models are the most widely used and 
accepted. DEN acts as alkylating agent for DNA bases 
which initiates the formation of neoplasms[11].
Chronic alcohol consumption causes morbidity and 
leads to broad spectrum of disorders from steatosis to 
steatohepatitis to cirrhosis and hepatocellular cancer[12]. 
Currently there are no animal models of HCC that eva-
luates the effect of ALD on HCC acceleration. In this 
study, we administered 6 doses of DEN to 4 wk old 
adult C57bl/6 male mice followed by 7 wk of Lieber 
DeCarli alcohol diet feeding. We report up-regulation of 
liver inflammatory cell infiltration and fibrotic markers 
in mice receiving alcohol + DEN. Further, alcohol 
+ DEN mice showed characteristic appearance of 
intrahepatic cysts and hepatic neoplastic foci at the end 
of the alcohol feeding compared to mice exposed to 
alcohol alone and DEN alone, respectively, supporting 
acceleration of HCC by ALD.
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MATERIALS AND METHODS
Animal model of HCC
To establish a mouse model of hepatocellular cancer 
based on the Lieber-DeCarli alcohol diet, we injected 
4 wk old C57bl/6 male mice with total 6 doses of 
DEN (Sigma, MO, United States) intraperitoneally. 
As shown in Figure 1A, a dose of 75 mg/kg DEN was 
administered weekly for the first 3 wk followed by a 
dose of 100 mg/kg DEN for next 3 wk. At week 8, the 
mice were randomly divided into alcohol and pair fed 
(control) groups. Age matched groups of mice without 
DEN were included in the study to understand the 
effect of chronic alcohol feeding. Depending on the 
experimental design, mice were fed 4% Lieber-Decarli 
alcohol diet or calorie matched control diet (Pair fed), 
(Bio-Serv, Flemington, NJ, United States) for 7 wk 
(Figure 1A). At sacrifice, blood and liver tissues were 
collected for further assays. The study protocol was 
approved by the Institutional Animal Use and Care 
Committee of the University of Massachusetts Medical 
School.
Magnetic resonance imaging
Magnetic resonance imaging (MRI) of liver was 
performed to monitor hyperplastic changes in liver. 
Images were obtained using 3T Philips Achieva 
whole-body MR scanner (Philips Medical Systems, 
Best, Netherlands) with a custom-made solenoid T/
R coil with a diameter of 30 mm. The animals were 
anesthetized with 5% isoflurane mixed with carbogen 
(95% O2/5% CO2) and were maintained with 1% 
to 2% isofluorane. Coronal T2-weighted spin echo 
images were acquired with respiratory triggering 
to reduce the motion artifacts. The respiration rate 
was monitored with an optical probe (Model 1025T 
Monitoring and Gating System, SA Instruments Inc, 
Stony Brook, NY, United States). The output signal 
from the respiration monitor was used to trigger, 
in real time, the MR acquisition. As a consequence 
Figure 1  Chronic alcohol enhances DEN induced hepatic injury. A: Experimental design of the adult mouse model of early hepatocellular carcinoma. B: 
Body weight of mice in each group per week. C: Three - five mice from each experimental group were bled every week and serum ALT was measured. The graph 
represents mean ALT levels of each group. In graphs B and C, values are given as mean ± SD, Dunnett’s multiple comparison were used to compare the means of 
multiple groups; (ap < 0.05 vs pair fed saline injected mice, cp < 0.05 vs pair fed DEN injected mice). ALT: Alanine aminotransferase; DEN: Diethyl nitrosamine; AFP: 
a-fetoprotein; MRI: Magnetic resonance imaging.
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of the triggered acquisition, the TR value of around 
2000 ms, corresponding to the respiration rate of 
around 30 bpm, was determined. Other imaging 
parameters were: echo time (TE) of 70 ms, flip angel 
of 90 degrees, TSE-factor of 8, number of average = 
4, matrix size of 148 × 120, field of view of 30 × 25 
mm2, slice thickness of 1 mm with no gap, acquisition 
time around 4 min for 22 slices. Hyperplastic nodules 
were distinguished from normal liver tissues on basis 
of differences in homogeneity and signal intensity. Pixel 
based nodule area quantitation was performed using 
ImageJ software.
Biochemical assays
Serum alanine aminotransferase (ALT) activity was 
determined using a kinetic method (D-TEK LLC, PA, 
United States). Serum AFP was assayed by ELISA 
(R&D systems, Minneapolis, MN, United States). 
Serum bilirubin was estimated using bilirubin assay kit 
(Abnova, Walnut, CA, United States) and the endoto-
xin levels were measured using LAL Chromogenic 
Endotoxin Quantitation Kit (Thermo Scientific, Rockford, 
IL, United States). Liver triglycerides were assayed in 
liver whole cell lysates using L-Type TriGlyceride M kit 
(Wako Diagnostics, Richmond, VA, United States).
RNA extraction and real-time PCR
Total RNA was extracted using the Direct-zol RNA 
MiniPrep according to the manufacturer’s instructions 
(Zymo Research, Irvin, CA, United States). RNA was 
quantified using Nanodrop 2000 (Thermo Scientific, 
Wilmington, DE). Complementary DNA (cDNA) synthesis 
was performed by reverse transcription of total RNA 
using the iScript Reverse Transcription Supermix 
(BIO-RAD, Hercules, CA, United States). Real-time 
quantitative PCR was performed using the CFX96 real-
time detection system (Bio-Rad Laboratories, Hercules, 
CA, United States). Primers were synthesized by IDT, 
Inc. (Coralville, IA, United States). Accumulation of 
PCR products was detected by monitoring the increase 
in fluorescence of double-stranded DNA-binding 
dye SYBR Green during amplification. Relative gene 
expression was calculated by the comparative cycle 
threshold (Ct) method. The expression of target genes 
was normalized to the house-keeping gene, 18S rRNA, 
in each sample and the fold-change in the target 
gene expression between experimental groups was 
expressed as a ratio. Melt-curve analysis was used to 
confirm the authenticity of the PCR products.
Western blotting
Whole cell lysates, were prepared from mouse livers 
as described previously[13]. Proteins of interest were 
detected by immunoblotting with specific primary 
antibodies against: Cyp2e1 (ab1252 Millipore), β-actin-
HRP (ab49900; Abcam). Respective horseradish 
peroxidase-labeled secondary antibodies were from 
Santacruz Biotechnology (Dallas, TX, United States). 
The specific immunoreactive bands of interest were 
detected by chemiluminescence (Bio-Rad, Hercules, 
CA, United States). The immunoreactive bands were 
quantified by densitometric analysis using the UVP 
System (Bio-Rad Laboratories, Hercules, CA, United 
States).
Histopathological analysis
Sections of formalin-fixed, paraffin-embedded livers 
were stained with hematoxylin and eosin, or Sirius Red 
and assessed for histological features of carcinoma and 
fibrosis. To assess steatosis, Oil Red O staining was 
performed on cryofrozen liver tissue sections (OCT). 
Immunohistochemistry staining for PCNA (ab29; 
Abcam), MPO (ab9535; Abcam) was performed on 
formalin-fixed, paraffin-embedded livers according to 
the manufacturer’s instructions. Images were acquired 
on a Nikon microscope at magnification mentioned in 
figure legends. The quantitation of the Oil Red O, Sirius 
Red staining was performed using ImageJ software.
Statistical analysis
Statistical significance was determined using two-tailed 
t-test; ANOVA and Dunnett’s multiple comparison 
post-test were used to compare the means of multiple 
groups. Data are shown as mean ± SD and were 
considered statistically significant at P < 0.05. GraphPad 
Prism 6.02 (GraphPad Software Inc., La Jolla, CA, 
United States) was used for analysis.
RESULTS
Chronic alcohol enhances DEN-induced hepatic injury
ALD and alcoholic cirrhosis are major risk factors for 
HCC development in humans[14]. Here we hypothesized 
that the alcoholic liver environment expedites liver 
tumor development after repeated administration 
of a chemical carcinogen, DEN. In this study, male 
C57bl/6 mice received 6 weekly DEN injections, 
starting at age of 4 wk followed by 7 wk of chronic 
alcohol administration (Figure 1A). Weekly body 
weight monitoring showed that compared to pair-fed 
mice, alcohol-fed saline-injected mice gained weight 
significantly after 7 wk of alcohol feeding. Both DEN 
injected pair-fed and DEN-injected alcohol-fed mice 
showed attenuated weight gain during the entire 
course of experiment compared to mice without DEN 
injection (Figure 1B).
Serum ALT, a marker of hepatic injury, was signi-
ficantly increased after the first DEN administration 
and remained elevated after repeated doses. In 
addition, co-administration of DEN and alcohol further 
increased ALT (weeks 8-9) that remained elevated in 
alcohol-fed mice. Introduction of alcohol feeding even 
in the saline injected group resulted in a significant 
Ambade A et al . Alcoholic liver disease promotes HCC
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and sustained increase in ALT compared to pair-fed 
control diet (Figure 1C). These results suggested that 
while DEN and alcohol, respectively induce liver injury, 
their combination results in synergistic hepatic injury 
leading to sustained high serum ALT levels.
Macrophage and neutrophil activation in the liver is 
increased in DEN exposed ALD
Previous reports showed that chronic alcohol feeding 
results in significant liver inflammation[15]. Human 
alcoholic hepatitis is characterized by liver injury, 
increased serum transaminases, increased bilirubin 
and inflammatory cell infiltration into the liver[16]. Thus, 
first, we assessed serum bilirubin which is increased 
in alcoholic hepatitis as well as in human HCC[17]. We 
found that similar to human patients with alcoholic 
hepatitis, serum bilirubin was increased in mice after 
chronic alcohol administration (Figure 2A). Serum 
bilirubin was also increased in mice that received DEN 
alone (Figure 2A). However, the greatest extent of 
serum bilirubin increase was found in alcohol-fed DEN-
injected mice compared to any other experimental 
groups. This was indicative of advanced liver disease 
and raised the possibility of HCC (Figure 2A). 
Chronic alcohol exposure also induces Kupffer cell 
activation and infiltration of macrophages into the liver 
and results in secretion of pro-inflammatory cytokines 
that drive inflammation in alcoholic hepatitis[18]. 
Kupffer cells and macrophages are the most abundant 
pro-inflammatory cell type in the liver and are known 
to contribute to ALDs[19]. Thus, next, we assessed the 
expression of the macrophage/Kupffer cell markers, 
F4/80, CD68 in the liver. The expression of the 
pan-macrophage marker, F4/80, was significantly 
elevated in all alcohol-fed mice with or without DEN. 
The macrophage activation marker, CD68, was up 
regulated to greater extent in alcohol-fed DEN-injected 
mice as compared to alcohol-fed saline-injected mice 
suggesting the presence of activated inflammatory 
macrophages in the liver (Figure 2B). Recent literature 
suggests that macrophages can be further classified 
into pro-inflammtory M1 or anti-inflammatory M2 
macrophages[20]. These macrophage subtypes express 
unique markers[21]. We found a significant increase 
in the expression of M1 macrophage markers, IL-
1β and iNOS, (Figure 2C) in livers of alcohol fed 
mice. Importantly, iNOS expression was significantly 
higher in alcohol fed-DEN injected mice compared to 
alcohol alone (Figure 2C). Livers from alcohol fed mice 
also showed higher expression of M2 macrophage 
markers, Arg1, CD163, IL-10 and CD206, compared 
to non-alcohol controls (Figure 2D) and CD206 the 
highest in alcohol fed-DEN injected mice (Figure 2D). 
These observations suggested increased macrophage 
recruitment to precancerous liver with mixed M1/M2 
phenotype.
Neutrophils play a significant role in alcoholic 
hepatitis and also contribute to HCC[22]. Other studies 
have shown that alcohol alone upregulated expression 
of the characteristic neutrophil markers, Ly6G, MPO 
and E-selectin[23]. In our study, messenger RNA levels 
of these neutrophil markers were significantly up-
regulated in alcohol-fed (Figure 3A) compared to pair-
fed mice. The highest expression of Ly6G, MPO and 
E-selectin was found in alcohol-fed DEN-injected mice 
as compared to any other experimental groups (Figure 
3A). DEN alone resulted in no change in neutrophil 
marker expression compared to saline injected controls 
(Figure 3A). We also confirmed the upregulation of 
MPO at the protein level using MPO immunostaining 
(Figure 3B) that showed significantly increased 
numbers of infiltrating neutrophils in alcohol-fed saline-
injected mice compared to pair-fed controls (Figure 
3B). Moreover, the highest levels of MPO staining, 
confirming neutrophil infiltration and activation, were 
present in the livers of DEN-injected alcohol-fed 
mice (Figure 3C). Taken together, our data showed a 
significant increase in key features of alcoholic hepatitis 
including increased serum bilirubin, a clinically relevant 
diagnostic marker, elevated macrophage, neutrophil 
after alcohol administration and an even greater 
elevation in all of these indices in the alcohol + DEN 
treated mice markers in our experimental model.
Chronic alcohol synergizes with DEN in induction of 
liver fibrosis
As we found sustained and increased liver injury and 
inflammation after DEN + alcohol administration, 
we next analyzed steatosis and fibrosis in the livers. 
There was a significant increase in steatosis in the 
livers of alcohol-fed mice compared to the pair-fed 
control as indicated by Oil-Red-O staining (Figure 
4A). Interestingly, alcohol-induced liver steatosis was 
attenuated in DEN-injected mice compared to saline-
injected alcohol-fed mice (Figure 4A). DEN alone did 
not induce steatosis (Figure 4A and B). Alcohol induced 
steatosis was further confirmed by measuring hepatic 
triglyceride content, which also showed reduction 
in alcohol-fed DEN-injected mice as compared to 
alcohol-fed saline-injected mice (Figure 4C). While 
steatosis is an early presentation of ALD, prolonged 
liver disease results in fibrosis that is considered as a 
sequential step towards HCC development[24]. Hence, 
we assessed the extent of fibrosis using Sirius Red 
staining. As shown in Figure 4D, alcohol-fed DEN-
injected mice showed significantly increased fibrosis 
by Sirius Red staining indicating the presence of liver 
fibrosis compared to all other groups (Figure 4D). The 
increased fibrosis was quantified in Figure 4E. Thus, 
our experimental model of HCC with DEN + alcohol 
Ambade A et al . Alcoholic liver disease promotes HCC
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showed minimal steatosis and significant fibrosis 
indicative of advanced liver disease.
Chronic alcohol induces serum endotoxin and activates 
Cyp2e1
Chronic alcohol exposure leads to an increase in 
levels of circulating endotoxin, which can activate the 
immune cells in the liver causing inflammation[25]. 
TLR4 signaling has been shown to contribute to 
HCC[26]. We observed a significant increase in serum 
endotoxin levels after alcohol feeding while there 
was no significant difference between the endotoxin 
levels of alcohol-fed DEN injected mice and alcohol 
alone fed mice, at the time of sacrifice (Figure 5A). 
Cyp2e1, the enzyme that metabolizes alcohol in liver, 
was upregulated at both mRNA and liver protein levels 
in alcohol fed mice (Figure 5B and C) as compared 
to pair fed or DEN alone mice. Interestingly, the liver 
protein levels of Cyp2e1 in alcohol + DEN mice were 
significantly lower than alcohol alone fed mice (Figure 
5D). This data supported the hypothesis of increased 
inflammation and Cyp2e1 activation after alcohol 
exposure in our experimental model.
Chronic alcohol induces cellular proliferation and 
expedites HCC
To ascertain the liver tumor and HCC development, 
we performed MRI on all experimental groups before 
sacrifice, at week 13 of age. The liver MRI revealed a 
few bright spots, characteristics of intrahepatic cysts, 
in DEN treated mice, however significantly higher 
numbers of hepatic cysts were present in the DEN + 
alcohol mice (Figure 6A). The increased numbers of 
intrahepatic cysts in DEN + alcohol mice were further 
confirmed by histology (Figure 6B). Livers of pair-fed 
or alcohol alone fed mice showed no lesions on MRI. 
The area of cysts from MRI data was quantified using 
ImageJ and shown in Figure 6C. In addition to hepatic 
cysts, histology evaluation revealed the presence 
of numerous liver nodules characterized by hepatic 
hyperplasia exclusively in alcohol-fed DEN-injected 
mice compared to all other experimental groups 
(Figure 6D). The pair-fed DEN-injected mice had very 
few intrahepatic cysts and no hepatic hyperplastic 
nodules. None of the alcohol fed or pair fed mice had 
cysts or hyperplastic nodules. These results indicated 
that alcoholic hepatitis expedited early liver tumor 
development.
Next, we assessed the expression of characteris-
tic HCC markers. The expression of AFP is directly 
associated with hepatocyte differentiation and HCC 
progression[27]. More importantly, AFP is the most 
commonly used noninvasive marker for HCC diag-
nosis[17]. We measured serum AFP levels at week 8 
(at the beginning of alcohol feeding) and at week 15 
(at the end of alcohol feeding). DEN alone increased 
serum AFP at both 8 and 15 wk while alcohol alone 
increased AFP only at 15 wk (Figure 7A). Importantly, 
there was a significant increase in serum AFP in alcohol 
+ DEN mice compared to the DEN alone or alcohol 
alone groups not only at 8 but also at 15 wk, indicating 
early regeneration and potentially, HCC development 
(Figure 7A and B).
Chronic alcohol feeding is reported to induce hepatic 
proliferation[28]. Thus, to estimate cell proliferation, 
we performed PCNA staining on liver tissue sections 
(Figure 7C). Immunohistochemistry staining for PCNA 
showed significantly higher number of PCNA positive 
nuclei in alcohol-fed DEN-injected mice compared to 
all other groups (Figure 7C). Of note, both alcohol-
fed saline-injected and pair-fed DEN-injected mice 
showed increased numbers of PCNA positive nuclei 
compared to pair-fed saline-injected controls (Figure 
7D). Taken together, our experimental model showed 
hepatic hyperplasia confirmed on histology, significant 
up regulation in AFP and cell proliferation, providing 
evidence for the synergistic action of alcohol as a 
tumor promoting agent in DEN-induced early HCC.
Figure 2  Alcoholic hepatitis induces macrophage polarization. A: Serum bilirubin was measured in serum samples at week 15; B: Liver mRNA levels of 
macrophage markers, F4/80, CD68; C: Liver mRNA levels of M1 macrophage markers, IL-1β, iNOS; D: Liver mRNA levels of M2 macrophage markers, Arg1, CD163, 
IL-10, and CD206. In graphs, values are given as mean ± SD, Dunnett’s multiple comparison were used to compare the means of multiple groups; ap < 0.05. NS: Not 
significant; DEN: Diethyl nitrosamine; IL: Interleukin; iNOS: Inducible nitric oxide synthase.
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Figure 3  Alcoholic hepatitis induces neutrophil infiltration. A: Liver mRNA levels of neutrophil markers, Ly6G, MPO and E-selectin; B: Representative 
myeloperoxidase (MPO) immunohistochemistry of hepatic sections (magnification × 200) from all experimental groups at 15 wk. Black arrows point to the positive 
staining; C: MPO positive cells were scored in at least 3 different microscopic fields for each mouse and plotted as bar graph. (n ≥ 5 mice per group). In graphs, 
values are given as mean ± SD, Dunnett’s multiple comparison were used to compare the means of multiple groups; ap < 0.05. NS: Not significant; DEN: Diethyl 
nitrosamine.
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DISCUSSION
Chronic alcohol use leads to alcoholic hepatitis and 
cirrhosis[14]. Epidemiological data suggests that chronic 
heavy alcohol consumption and ALD is a significant 
risk factor towards the development of HCC[29]. In this 
study, we introduce a mouse model that demonstrates 
that chronic alcohol feeding resulting in alcoholic 
hepatitis in adult mice, expedites DEN (chemical) 
induced early liver tumor development. We found 
that features of human alcoholic hepatitis including 
inflammation, steatosis and fibrosis were all present in 
DEN-injected mice after alcohol feeding and resulted in 
present numbers of early HCC neoplastic foci (Figure 
8). Our data indicate that increased neutrophil and 
macrophage activation is triggered in the alcoholic 
liver tissue microenvironment and may contribute 
to acceleration of HCC (Figure 8). In addition to 
steatohepatitis, liver fibrosis was also present in 
DEN + alcohol treated mice as indicated by Sirius 
Red staining. Further, our model showed increased 
numbers of intrahepatic cysts by the MRI that were 
confirmed as hepatobiliary cysts by histology and are 
features of early hepatobiliary cancer. Our model also 
Sirius red staining
Pair fed + saline                                                               Alcohol fed + saline
Pair fed + DEN                                                                 Alcohol fed + DEN
Figure 4  Chronic alcohol synergizes with diethyl nitrosamine in hepatocellular carcinoma development. A: Representative Oil Red O staining of hepatic 
sections (200 × magnification) from all experimental groups at 15 wk; B: Bar graph shows percent Oil Red O stained area in groups that was quantified using ImageJ 
software. For quantification, at least 3 different microscope fields were scored for each mouse (n ≥ 5 mice per group); C: Liver triglycerides were estimated at week 
15; D: Representative Sirius Red staining of hepatic sections (magnification × 100) from all experimental groups at 15 wk. E: For quantification of fibrosis, at least 3 
different microscope fields at 10x magnification were scored for each mouse (n ≥ 5 mice per group). Bar graph shows percent Sirius Red positive area quantified 
using ImageJ. In graphs, values are given as mean ± SD, Dunnett’s multiple comparison were used to compare the means of multiple groups; ap < 0.05. NS: Not 
significant; DEN: Diethyl nitrosamine.
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Figure 5  Chronic alcohol increases serum endotoxin levels and activates Cyp2e1. A: Serum endotoxin; B: Liver Cyp2e1 mRNA levels; C: Representative 
western blot showing liver Cyp2e1 protein levels. β-actin was used as loading control for western blot; D: Relative density of Cyp2e1 western blot signal. In graphs, 
values are given as mean ± SD, Dunnett’s multiple comparison were used to compare the means of multiple groups; ap < 0.05. NS: Not significant; DEN: Diethyl 
nitrosamine.
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Figure 6  Chronic alcohol expedites hepatocellular carcinoma development. A: T2-weighted MRI of liver in coronal section at week 13. Arrows denote 
intrahepatic cysts. B: Representative HE stained intrahepatic cysts observed in all DEN injected mice (100X magnification). Note the higher number of cysts in alcohol 
+ DEN mice. C: Quantification of cyst area using ImageJ. D: Representative HE stained liver sections from all treatment groups (magnification × 100) at week 15. The 
hepatic hyperplasia (encircled in black dotted line) was exclusively observed in alcohol + DEN mice. In graph (C), values are given as mean ± SD, Dunnett’s multiple 
comparison were used to compare the means of multiple groups; ap < 0.05, pair fed vs alcohol fed. ND: Not detected; DEN: Diethyl nitrosamine.
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Figure 7  Chronic alcohol induces serum AFP and cellular proliferation. A: Fold changes in serum AFP levels at week 8 and week 15; B: Liver AFP mRNA levels 
at week 15; C: Representative immunostaining images for proliferating cell nuclear antigen (PCNA) at week 15 (magnification × 400). Arrows point to positive staining; 
D: PCNA positive nuclei were scored in at least 3 different microscopic fields for each mouse and plotted as bar graph on the right. (n ≥ 5 mice per group). In graphs, 
values are given as mean ± SD, Dunnett’s multiple comparison were used to compare the means of multiple groups; ap < 0.05. NS: Not significant; DEN: Diethyl 
nitrosamine; AFP: a-fetoprotein.
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showed significant induction in serum AFP, one of the 
well-established markers of HCC, upon alcohol feeding 
in the DEN-injected mice. Finally, our data showed 
enhanced cellular proliferation in response to chronic 
alcohol feeding which promoted progression to HCC. 
DEN has been used since the 1960s to induce 
HCCs in laboratory animals, and is the most widely 
used chemical to induce liver cancer in mice[10]. DEN 
undergoes metabolic activation in hepatocytes by 
enzymes of the cytochrome P450 family and acts as a 
complete carcinogen, if injected in mice younger than 2 
wk, when hepatocytes are still actively proliferating[30]. 
When administered to adult mice, tumor promotion is 
required and can be achieved by phenobarbital, carbon 
tetrachloride, partial hepatectomy. Our experimental 
model used 4 wk old male mice and provided evidence 
for the role of alcohol as tumor promoting agent in 
adult mice. In our study, male mice were chosen 
because of the higher prevalence of HCC in males 
compared to females in humans[3]. Irrespective of 
the promoting agent used, DEN based HCC models 
take at least 5 mo to show the first signs of tumor. 
Our model using alcohol as a tumor promoting agent 
demonstrated the first signs of early HCC in a much 
shorter time of 3 mo.
Although several carcinogen initiated HCC animal 
models have been described, none of them so far 
evaluated alcoholic hepatitis and ALD as a tumor 
promoting factor in wild-type mice[9]. A recent study 
performed in neonate mice combined chronic alcohol 
exposure in the drinking water with DEN injection 
and showed tumors at 48 wk[12]. However, alcohol 
administration in the drinking water does not cause 
ALD[31]. In our study, we employed the Lieber-DeCarli 
alcohol feeding model that results in features of 
human ALD including steatosis, inflammation and 
liver fibrosis[32]. By utilizing adult mice and the Lieber-
DeCarli alcohol diet, our model shows acceleration of 
early hepatobiliary tumors after a chemical carcinogen 
exposure with some histopathological resemblance to 
human ALD.
Chemical toxins and viral agents are the two 
well known etiologies of hepatocellular cancer[1]. 
Irrespective of the underlying etiology, cellular 
inflammation is the common feature that has been 
shown to be present in human HCC patients as well 
as animal models[33]. It is also known that persistent 
inflammation in the absence of infection increases 
the risk and expedites the development of cancer. 
Inflammation in the liver is one of the hallmarks of 
alcoholic hepatitis[33] and it was prominent in our 
model with the highest level in alcohol-fed DEN treated 
mice. Activation and recruitment of neutrophils and 
macrophages to the liver is a well-known feature of 
alcoholic hepatitis[19,22], steatohepatitis and ALD[34]. 
In our experiments, we found increased expression 
and activation of neutrophils and macrophages in 
alcohol-fed mice and markers of inflammation were 
even higher in mice with liver tumors after DEN + 
alcohol feeding. Alcohol-induced sensitization of liver 
macrophages to portal endotoxin is a hallmark of 
ALD[35]. LPS recognition by TLR4 on macrophages and 
other cell types in the liver, activation of downstream 
signaling pathways culminating in activation of 
transcription factors such as NF-κB, AP-1 leads to 
increased inflammatory cytokine production in ALD. 
Recent literature suggests that macrophages can be 
further classified into pro-inflammatory M1 or anti-
inflammatory M2 macrophages[20]. The M1 phenotype 
is characterized by the expression of high levels of 
proinflammatory cytokines, high production of reactive 
nitrogen and oxygen intermediates, promotion of Th1 
response, and strong microbicidal and tumoricidal 
activity[20,36]. The alternatively activated or M2 
macrophages are often referred to as tumor associated 
macrophages (TAMs)[20]. We observed a significant 
induction of both M1 (TNFa, iNOS) and M2 markers 
(Arg1, CD163, CD206) in our experimental model. 
The presence of M1 macrophages is consistent with 
the increased proinflammatory activation in ALD. This 
Figure 8  Multi-factorial effects of ethanol in hepatocellular carcinoma acceleration. HCC: Hepatocellular carcinoma. 
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increase in M2 macrophage is likely suggestive of 
the presence of TAMs in the liver. TAMs represent the 
major inflammatory component of the stroma of liver 
cancer and can affect different aspects of the neoplastic 
transformation of the tissue. Many observations indicate 
that TAMs express several M2-associated pro-tumoural 
functions, including promotion of angiogenesis, matrix 
remodeling and suppression of adaptive immunity. 
The pro-tumoural role of TAMs in cancer is further 
supported by clinical studies that found a correlation 
between the high macrophage content of tumors 
and poor patient prognosis. TAMs represent a unique 
and distinct M2-skewed myeloid population and are 
now recognized as a potential target for anti-cancer 
therapy[37]. Therefore, we mixed M1/M2 MΦ presence 
with the increase in M2 macrophage markers observed 
in our model may be responsible for promoting tumor 
development in the DEN exposed alcohol-fed mice.
Alcohol is primarily metabolized in hepatocytes and 
its metabolites generate ROS, cause inflammation and 
steatosis. Long term alcohol exposure induces a state 
of chronic inflammation in the liver[38]. Both DEN and 
alcohol induce Cyp2E1, and the chronic alcoholic injury 
induced in our model synergized with the chemical 
injury to increase hepatocyte proliferation leading 
to appearance of early neoplastic foci found in our 
experimental model. In the context of cancer-related 
inflammation, key intracellular signal transducers have 
been identified both in preneoplastic cells as well as in 
inflammatory cells. Among these signaling pathways, 
sustained activation of transcription factors including 
NF-κB, p53, HIF-1a, β-catenin/Wnt, and Nrf2 in liver 
leads to chronic inflammation that is responsible 
for cancer progression[39]. Thus, the inflammation 
associated with alcoholic hepatitis may be a significant 
contributing factor to HCC development in alcohol fed 
DEN injected mice.
In addition to cellular inflammation, the alcohol 
fed DEN injected mice showed sustained higher ALT 
levels. Increased ALT levels are indicator of hepatocyte 
damage and can be used reliably as a marker of liver 
injury[40]. Initially in our experimental model, the ALT 
levels were significantly higher in all DEN injected 
mice and ALT returned to baseline after cessation of 
DEN administration. However, the alcohol fed mice 
showed sustained the higher ALT levels suggesting 
sustained liver injury. DEN acts as an alkylating 
agent for DNA bases which initiates the formation of 
neoplasms[11]. It has been proposed that the charged 
nucleophilic intermediates of DEN attack DNA bases 
thereby leading to mutations which initiate cellular 
transformation[11]. Chemical carcinogens including 
DEN exert their effect by generating ROS during their 
metabolism in the liver, which is responsible for DNA 
damage associated with increased risk of cancer 
development[39]. Importantly, DEN is metabolized in the 
liver by Cyp2E1, the same enzyme that metabolizes 
alcohol[41]. We also observed significantly higher TBARS 
in alcohol fed DEN injected mice, compared to alcohol 
alone mice (data not shown). Hence, it is possible that 
the hepatocytes from alcohol fed DEN injected mice 
are exposed to extremely higher ROS in addition to 
DNA damage which may expedite their transformation 
into early HCC observed in this group exclusively.
The expression of AFP is directly associated with 
hepatocyte differentiation[27]. Elevated levels of serum 
AFP are reported in alcoholic hepatitis patients[42]. 
However, as compared to alcoholic hepatitis patients, 
the AFP levels are much higher in human HCC 
patients[43]. Some reports show a clinical correlation 
between serum AFP and severity of liver disease[44]. 
Our data of serum AFP levels at week 8 and 15 clearly 
show the role of alcohol in stimulating AFP expression 
which can be correlated to advanced liver disease 
such as HCC. In addition to hepatocytes, the liver 
progenitor cells (LPC) also produce AFP during their 
cellular differentiation[45]. The LPCs play an important 
role in liver regeneration and homeostasis[46,47]. 
Increased serum AFP in our experimental model is also 
indicative of enhanced proliferation of LPCs which may 
be responding to chronic liver injury caused by alcohol 
feeding. This regenerative response by LPCs may also 
contribute to HCC development.
Chronic alcohol feeding is reported to induce 
Cyclin D1 protein that corresponds with enhanced 
hepatic proliferation[28]. More recently, Lanthier et al[48] 
reported that alcoholic hepatitis patients demonstrated 
a significant invasion of LPC and a higher number of 
proliferating hepatocytes compared to controls. This 
study on human alcoholic hepatitis patients suggests 
that hepatic cell proliferation plays a pivotal role in the 
prognosis of alcoholic hepatitis and HCC. A significantly 
higher number of PCNA positive cells in DEN + alcohol 
mice provide another evidence for the role of alcohol 
as inducer of hepatocyte and LPC proliferation.
Chronic liver injury such as long term alcohol 
exposure leads to steatohepatitis, hepatitis which 
can progress to fibrosis[24]. Hepatic fibrosis is an 
injury healing process in which excessive connective 
tissue accumulates in the liver[49]. The profibrotic 
factors like collagen are overproduced to assist the 
expansion of new hepatocytes. Hepatic fibrosis can 
progress to cirrhosis and in few cases to HCC[24]. In 
our experimental model of HCC, the alcohol fed DEN 
injected mice showed significantly higher fibrosis as 
compared to alcohol fed (alone) or DEN injected (alone) 
mice. The molecular pathways associated with fibrosis 
are very similar to liver regeneration, a cellular process 
in which mature terminally differentiated hepatocytes 
proliferate to replace the injured cells[50]. In adult mice, 
mature hepatocytes exist in a growth-arrested (G0) 
state which, after liver injury, leave their G0 state and 
enter the proliferative stages of the cell cycle during 
which they duplicate necessary components and 
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synthesize new proliferation-specific molecules (G1 
phase), replicate their DNA (S phase), and divide (M 
phase)[51]. It is conceivable that in our experimental 
model, hepatocytes with damaged DNA undergo 
multiple rounds of proliferation to complete the 
regeneration response. However, due to their damaged 
DNA, continue to proliferate leading to HCC. Other 
probable explanation could be that the hepatocytes 
with DEN induced DNA damage are exposed to 
increased amount of ROS and inflammation due to 
chronic alcohol exposure, which leads to their constant 
proliferation resulting in HCC development. These 
hypotheses can be the focus of future studies.
In conclusion, by combining multiple injections 
of DEN prior to chronic Lieber-DeCarli alcohol diet 
feeding, we developed a mouse model that displays 
the features of early HCC. Importantly, our model 
involves adult mice with alcoholic hepatitis, liver 
inflammation, cellular regeneration, and fibrosis, all 
the features associated with pathogenesis of human 
HCC. We believe that availability of such a model will 
provide unique opportunities to understand alcohol 
associated molecular and cellular mechanisms related 
to HCC.
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Background
Hepatocellular carcinoma (HCC) is the most common liver cancer, and 
worldwide it represents the fifth most common primary cancer diagnosed 
in patients. Chronic alcohol consumption causes morbidity and leads to 
broad spectrum of disorders from steatosis to steatohepatitis to cirrhosis and 
hepatocellular cancer.
Research frontiers
Several animal models have been reported that mimic different steps leading to 
HCC. Currently there are no animal models of HCC that evaluate the effect of 
alcoholic liver disease on HCC acceleration.
Innovations and breakthrough
In this study, the authors administered 6 doses of diethyl nitrosamine (DEN) to 
4 wk old adult C57bl/6 male mice followed by 7 wk of Lieber-DeCarli alcohol 
diet feeding. They found that features of human alcoholic hepatitis including 
inflammation, steatosis and fibrosis were all present in DEN-injected mice 
after alcohol feeding and resulted in higher numbers of early HCC neoplastic 
foci. The data indicate that increased neutrophil and macrophage activation is 
triggered in the alcoholic liver tissue microenvironment and may contribute to 
acceleration of HCC.
Applications
This combination of carcinogen pre-exposure and chronic alcohol consumption 
presents one of the most unique phenomenons of chronic alcohol leading to 
progression of HCC that occurs in humans. This availability of such a model will 
provide unique opportunities to understand alcohol associated molecular and 
cellular mechanisms related to HCC.
Terminology
Lieber-DeCarli diet, a commercially available, carefully designed and well 
characterized rodent diet intended to mimic the clinical situation in which the 
various effects of alcohol occur in the setting of liver changes characterized by 
a fatty liver and inflammation.
Peer-review
This is an interesting manuscript devoted to increased DEN-induced HCC 
development by alcohol. An important aspect of this study is that mice were fed 
not ethanol in water, but ethanol in Lieber-DeCarli diet (pair-feeding), which by 
itself induces liver injury.
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